Evidence map›Paper›PMID 38645262›Full record

ArticleResearch square2024

Regulation of Enhancers by SUMOylation Through TFAP2C Binding and Recruitment of HDAC Complex to the Chromatin.

Tharindumala Abeywardana, Xiwei Wu, Shih-Ting Huang, Grace Aldana Masangkay, Andrei S Rodin, Sergio Branciamore, Grigoriy Gogoshin, Arthur Li, Li Du, Neranjan Tharuka and 2 more

Open access · greenAbstract readPreprint
In one paragraph

Article in Research square, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Tharindumala AbeywardanaUniversity of California, San Diego.
Xiwei WuToni Stephenson Lymphoma Center Beckman Research Institute, City of Hope.
Shih-Ting HuangUniversity of California, San Diego.
Grace Aldana MasangkayToni Stephenson Lymphoma Center Beckman Research Institute, City of Hope.
Andrei S RodinToni Stephenson Lymphoma Center Beckman Research Institute, City of Hope.
Sergio BranciamoreToni Stephenson Lymphoma Center Beckman Research Institute, City of Hope.
Grigoriy GogoshinToni Stephenson Lymphoma Center Beckman Research Institute, City of Hope.
Arthur LiToni Stephenson Lymphoma Center Beckman Research Institute, City of Hope.
Li DuToni Stephenson Lymphoma Center Beckman Research Institute, City of Hope.
Neranjan TharukaUniversity of California, San Diego.
Ross TomainoHarvard Medical School Taplin Mass Spectrometry Facility.
Yuan ChenUniversity of California, San Diego.
City Of Hope National Medical Center · USUniversity of California San Diego · USHarvard University · US

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI John Charles Williams · 1985 to 2026
$86.3M
Targeting c-Myc and Proteasome Inhibitor Resistance in Multiple MyelomaR01CA212119 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHEN, YUAN · 2017 to 2021
$2.8M
SUMO Modification and Cancer TherapyR01CA265410 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHEN, YUAN · 2021 to 2025
$2.5M
K-Ras sumoylation in cell proliferation and transformationR01CA216987 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHEN, YUAN, DAI, WEI · 2017 to 2021
$2.5M
An integrated toolkit combining computational systems biology techniques with molecular dynamics simulations to delineate functionality of GPCRsR01LM013876 · NLM · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI RODIN, ANDREI, VAIDEHI, NAGARAJAN · 2022 to 2025
$1.5M
Scalable Bayesian Network analysis of multimodal FACS and SUMOylation data, with generalization to other big mixed biological datasetsR01LM013138 · NLM · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI RODIN, ANDREI · 2020 to 2022
$776k
NCI NIH HHS P30 CA033572NCI NIH HHS R01 CA212119NCI NIH HHS R01 CA216987NCI NIH HHS R01 CA265410NLM NIH HHS R01 LM013138NLM NIH HHS R01 LM013876
6 · The paper itself

Abstract

Enhancers are fundamental to gene regulation. Post-translational modifications by the small ubiquitin-like modifiers (SUMO) modify chromatin regulation enzymes, including histone acetylases and deacetylases. However, it remains unclear whether SUMOylation regulates enhancer marks, acetylation at the 27th lysine residue of the histone H3 protein (H3K27Ac). To investigate whether SUMOylation regulates H3K27Ac, we performed genome-wide ChIP-seq analyses and discovered that knockdown (KD) of the SUMO activating enzyme catalytic subunit UBA2 reduced H3K27Ac at most enhancers. Bioinformatic analysis revealed that TFAP2C-binding sites are enriched in enhancers whose H3K27Ac was reduced by UBA2 KD. ChIP-seq analysis in combination with molecular biological methods showed that TFAP2C binding to enhancers increased upon UBA2 KD or inhibition of SUMOylation by a small molecule SUMOylation inhibitor. However, this is not due to the SUMOylation of TFAP2C itself. Proteomics analysis of TFAP2C interactome on the chromatin identified histone deacetylation (HDAC) and RNA splicing machineries that contain many SUMOylation targets. TFAP2C KD reduced HDAC1 binding to chromatin and increased H3K27Ac marks at enhancer regions, suggesting that TFAP2C is important in recruiting HDAC machinery. Taken together, our findings provide insights into the regulation of enhancer marks by SUMOylation and TFAP2C and suggest that SUMOylation of proteins in the HDAC machinery regulates their recruitments to enhancers.

Indexed as

AP-2enhancersH3K27Achistone remodelingRNA splicingspliceosomeSUMOSUMOylationTFAP2C

Identifiers

PMID38645262
PMCPMC11030540
OpenAlexW4393434652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.